Unknown

Dataset Information

0

Novel-Substituted Heterocyclic GABA Analogues. Enzymatic Activity against the GABA-AT Enzyme from Pseudomonas fluorescens and In Silico Molecular Modeling.


ABSTRACT: ?-Aminobutyric acid (GABA) is the most important inhibitory neurotransmitter in the central nervous system, and a deficiency of GABA is associated with serious neurological disorders. Due to its low lipophilicity, there has been an intensive search for new molecules with increased lipophilicity to cross the blood-brain barrier to raise GABA concentrations. We have designed and evaluated in vitro and in silico some new analogues of GABA, where the nitrogen atom at the ?-position is embedded in heterocyclic scaffolds and determined their inhibitory potential over the GABA-AT enzyme from Pseudomonas fluorescens. These modifications lead to compounds with inhibitory activity as it occurs with compounds 18a and 19a. The construction of Pseudomonas fluorescens and human GABA-AT models were carried out by homology modeling. Docking assays were done for these compounds over the GABA-AT enzyme models where 19a showed a strong interaction with both GABA-AT enzymes.

SUBMITTER: Tovar-Gudino E 

PROVIDER: S-EPMC6099672 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Novel-Substituted Heterocyclic GABA Analogues. Enzymatic Activity against the GABA-AT Enzyme from <i>Pseudomonas fluorescens</i> and In Silico Molecular Modeling.

Tovar-Gudiño Erika E   Guevara-Salazar Juan Alberto JA   Bahena-Herrera José Raúl JR   Trujillo-Ferrara José Guadalupe JG   Martínez-Campos Zuleyma Z   Razo-Hernández Rodrigo Said RS   Santiago Ángel Á   Pastor Nina N   Fernández-Zertuche Mario M  

Molecules (Basel, Switzerland) 20180509 5


γ-Aminobutyric acid (GABA) is the most important inhibitory neurotransmitter in the central nervous system, and a deficiency of GABA is associated with serious neurological disorders. Due to its low lipophilicity, there has been an intensive search for new molecules with increased lipophilicity to cross the blood-brain barrier to raise GABA concentrations. We have designed and evaluated in vitro and in silico some new analogues of GABA, where the nitrogen atom at the γ-position is embedded in he  ...[more]

Similar Datasets

| S-EPMC6278377 | biostudies-literature
| S-EPMC1206919 | biostudies-other
| S-EPMC3990056 | biostudies-literature
| S-EPMC2937996 | biostudies-literature
| S-EPMC6296634 | biostudies-literature
| S-EPMC2293227 | biostudies-literature
| S-EPMC10275814 | biostudies-literature
| S-EPMC8935357 | biostudies-literature
| S-EPMC5203634 | biostudies-literature